The Cambridge site of an international biotechnology company will cease manufacturing, leaving 150 people without a job.

Intuitive Surgical, an American biotechnology company, introduced DaVinci surgical robots in the late 1990s, and they became ...

A Cambridge-based company developing gene therapies for rare diseases is laying off more than a third of its workforce.

The Food and Drug Administration granted Expanded Access Program authorization for NKGen's investigational drug application.

Biogen is investing $2 billion in its U.S. manufacturing footprint — but not in Massachusetts, where the drug company is ...

The Food and Drug Administration on Monday named George Tidmarsh, a longtime biotech executive who has a background in ...

Biotech company CRISPR Therapeutics has a market cap of around $5 billion, but it has the potential to be much more valuable ...

Executive Chairman & CEO of the Company to Participate in a Fireside Chat Philadelphia, Pennsylvania--(Newsfile Corp. - July 21, 2025) - Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company") ...

New board members bring decades of experience in company building, corporate strategy, commercialization, and business ...

Top experts from Amgen, CBIZ & Intrepid discuss 2025 trends in healthcare, biotech, and life sciences. Explore key insights ...

Alkermes’ investigational drug helped people with a type of narcolepsy stay awake during the day in a mid-stage trial.

Amylyx is a high-risk biotech targeting rare diseases with strong cash reserves. Key trials soon may drive a 40% stock upside ...